Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$50,328
+$6,830 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#4,068
of 4,150 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFS Advisors, LLC holds $238,324 across 8 Drug Manufacturers - General names. ABBV ranks #2 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
597 | $76,714 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
200 | $50,328 | |
| 3 | PFE |
Pfizer Inc
|
1,820 | $43,825 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
579 | $33,361 | |
| 5 | JNJ |
Johnson & Johnson
|
72 | $18,285 | |
| 6 | LLY |
ELI LILLY & Co
|
10 | $11,994 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
24 | $3,032 | |
| 8 | OGN |
Organon & Co.
|
58 | $785 |
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,328 | 200 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $43,498 | 200 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $45,698 | 200 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $46,308 | 200 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $37,124 | 200 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $104,760 | 500 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $88,850 | 500 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $39,496 | 200 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $34,304 | 200 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $36,420 | 200 | Shares | Sole | 2024-04-04 | |
| No filing history on record for this holder in this stock. | ||||||